Biocon is expected to report 24% jump in its first quarter FY12 profit after tax to Rs 95 crore against Rs 76.7 crore in the year ago period.
Revenues are seen going down 19% to Rs 538 crore from Rs 664 crore year-on-year.
EBITDA is likely to go up 13% to Rs 150 crore from Rs 133 crore year-on-year. Operating profit margin too is seen improving at 27.8% versus 20% Watch out for
Topline decline mainly due to absence of Axicorp
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
